United States Axitinib Market Report 2017

December 2017 | 103 pages | ID: UF8CD66E698EN
QYResearch

Abstracts

In this report, the United States Axitinib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Axitinib in these regions, from 2012 to 2022 (forecast).

United States Axitinib market competition by top manufacturers/players, with Axitinib sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Injection
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Renal Cancer Treatment
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Axitinib Market Report 2017

1 AXITINIB OVERVIEW

1.1 Product Overview and Scope of Axitinib
1.2 Classification of Axitinib by Product Category
  1.2.1 United States Axitinib Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Axitinib Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Injection
  1.2.4 Others
1.3 United States Axitinib Market by Application/End Users
  1.3.1 United States Axitinib Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Renal Cancer Treatment
  1.3.3 Others
1.4 United States Axitinib Market by Region
  1.4.1 United States Axitinib Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Axitinib Status and Prospect (2012-2022)
  1.4.3 Southwest Axitinib Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Axitinib Status and Prospect (2012-2022)
  1.4.5 New England Axitinib Status and Prospect (2012-2022)
  1.4.6 The South Axitinib Status and Prospect (2012-2022)
  1.4.7 The Midwest Axitinib Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Axitinib (2012-2022)
  1.5.1 United States Axitinib Sales and Growth Rate (2012-2022)
  1.5.2 United States Axitinib Revenue and Growth Rate (2012-2022)

2 UNITED STATES AXITINIB MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Axitinib Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Axitinib Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Axitinib Average Price by Players/Suppliers (2012-2017)
2.4 United States Axitinib Market Competitive Situation and Trends
  2.4.1 United States Axitinib Market Concentration Rate
  2.4.2 United States Axitinib Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Axitinib Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES AXITINIB SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Axitinib Sales and Market Share by Region (2012-2017)
3.2 United States Axitinib Revenue and Market Share by Region (2012-2017)
3.3 United States Axitinib Price by Region (2012-2017)

4 UNITED STATES AXITINIB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Axitinib Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Axitinib Revenue and Market Share by Type (2012-2017)
4.3 United States Axitinib Price by Type (2012-2017)
4.4 United States Axitinib Sales Growth Rate by Type (2012-2017)

5 UNITED STATES AXITINIB SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Axitinib Sales and Market Share by Application (2012-2017)
5.2 United States Axitinib Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES AXITINIB PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Axitinib Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview

7 AXITINIB MANUFACTURING COST ANALYSIS

7.1 Axitinib Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Axitinib

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Axitinib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Axitinib Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES AXITINIB MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Axitinib Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Axitinib Sales Volume Forecast by Type (2017-2022)
11.3 United States Axitinib Sales Volume Forecast by Application (2017-2022)
11.4 United States Axitinib Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Axitinib
Figure United States Axitinib Market Size (K MT) by Type (2012-2022)
Figure United States Axitinib Sales Volume Market Share by Type (Product Category) in 2016
Figure Injection Product Picture
Figure Others Product Picture
Figure United States Axitinib Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Axitinib by Application in 2016
Figure Renal Cancer Treatment Examples
Table Key Downstream Customer in Renal Cancer Treatment
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Axitinib Market Size (Million USD) by Region (2012-2022)
Figure The West Axitinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Axitinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Axitinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Axitinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Axitinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Axitinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Axitinib Sales (K MT) and Growth Rate (2012-2022)
Figure United States Axitinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Axitinib Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Axitinib Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Axitinib Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Axitinib Sales Share by Players/Suppliers
Figure 2017 United States Axitinib Sales Share by Players/Suppliers
Figure United States Axitinib Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Axitinib Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Axitinib Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Axitinib Revenue Share by Players/Suppliers
Figure 2017 United States Axitinib Revenue Share by Players/Suppliers
Table United States Market Axitinib Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Axitinib Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Axitinib Market Share of Top 3 Players/Suppliers
Figure United States Axitinib Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Axitinib Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Axitinib Product Category
Table United States Axitinib Sales (K MT) by Region (2012-2017)
Table United States Axitinib Sales Share by Region (2012-2017)
Figure United States Axitinib Sales Share by Region (2012-2017)
Figure United States Axitinib Sales Market Share by Region in 2016
Table United States Axitinib Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Axitinib Revenue Share by Region (2012-2017)
Figure United States Axitinib Revenue Market Share by Region (2012-2017)
Figure United States Axitinib Revenue Market Share by Region in 2016
Table United States Axitinib Price (USD/MT) by Region (2012-2017)
Table United States Axitinib Sales (K MT) by Type (2012-2017)
Table United States Axitinib Sales Share by Type (2012-2017)
Figure United States Axitinib Sales Share by Type (2012-2017)
Figure United States Axitinib Sales Market Share by Type in 2016
Table United States Axitinib Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Axitinib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Axitinib by Type (2012-2017)
Figure Revenue Market Share of Axitinib by Type in 2016
Table United States Axitinib Price (USD/MT) by Types (2012-2017)
Figure United States Axitinib Sales Growth Rate by Type (2012-2017)
Table United States Axitinib Sales (K MT) by Application (2012-2017)
Table United States Axitinib Sales Market Share by Application (2012-2017)
Figure United States Axitinib Sales Market Share by Application (2012-2017)
Figure United States Axitinib Sales Market Share by Application in 2016
Table United States Axitinib Sales Growth Rate by Application (2012-2017)
Figure United States Axitinib Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Axitinib Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Axitinib Sales Growth Rate (2012-2017)
Figure Pfizer Axitinib Sales Market Share in United States (2012-2017)
Figure Pfizer Axitinib Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Axitinib
Figure Manufacturing Process Analysis of Axitinib
Figure Axitinib Industrial Chain Analysis
Table Raw Materials Sources of Axitinib Major Players/Suppliers in 2016
Table Major Buyers of Axitinib
Table Distributors/Traders List
Figure United States Axitinib Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Axitinib Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Axitinib Price (USD/MT) Trend Forecast (2017-2022)
Table United States Axitinib Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Axitinib Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Axitinib Sales Volume (K MT) Forecast by Type in 2022
Table United States Axitinib Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Axitinib Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Axitinib Sales Volume (K MT) Forecast by Application in 2022
Table United States Axitinib Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Axitinib Sales Volume Share Forecast by Region (2017-2022)
Figure United States Axitinib Sales Volume Share Forecast by Region (2017-2022)
Figure United States Axitinib Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources